IRD
NASD Opus Genetics, Inc.$4.42 ↓ -0.04 (-0.90%) Trading Down from the previous close of $4.46
- YTD change
- +119.90%
- vs 20-day SMA
- -11.69%
- vs 200-day SMA
- +9.57%
Price ranges
Price & Performance
-1.04 (-18.91%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 37.5% away from all-time highs of $7.07
- IRD is up 120% since the beginning of the year
- IRD is up 122% over the past 12 months
- IRD is down 27% over the past 1 month
- 16% of all IRD investors are betting against IRD
IRD reads neutral: price sits above one of the two key moving averages, the 12-month move is +124.1%.
- Previous minute
- -$0.01
- Last hour
- -$0.07
- Last 5 days
- -2.00%
- vs 8-day SMA
- -3.16%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.